NCT03879018 Retraining Reaching in Cerebellar Ataxia
| NCT ID | NCT03879018 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
| Condition | Cerebellar Ataxia |
| Study Type | INTERVENTIONAL |
| Enrollment | 18 participants |
| Start Date | 2019-08-01 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 18 participants in total. It began in 2019-08-01 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to test for benefits of reinforcement based training paradigm versus standard practice over weeks for improving reaching movements in people with ataxia.
Eligibility Criteria
Inclusion Criteria: * Cerebellar damage from stroke, tumor or degeneration * Age 22-80 Exclusion Criteria: * Clinical or MRI evidence of damage to extracerebellar brain (e.g. multiple system atrophy) * Extrapyramidal symptoms, peripheral vestibular loss, or sensory neuropathy * Dementia ( Mini-Mental State exam \> 22) * Pain that interferes with the tasks * Vision loss that interferes with the tasks
Contact & Investigator
Amy J Bastian, PhD, PT
PRINCIPAL INVESTIGATOR
Kennedy Krieger Institute and Johns Hopkins School of Medicine
Frequently Asked Questions
Who can join the NCT03879018 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, up to 80 Years, studying Cerebellar Ataxia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03879018 currently recruiting?
Yes, NCT03879018 is actively recruiting participants. Contact the research team at agonza30@jhmi.edu for enrollment information.
Where is the NCT03879018 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT03879018 clinical trial?
NCT03879018 is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.. The principal investigator is Amy J Bastian, PhD, PT at Kennedy Krieger Institute and Johns Hopkins School of Medicine. The trial plans to enroll 18 participants.